Vernakalant Facilitated Electrical Cardioversion: A Randomized, Open Label Pilot Study Comparing Intravenous Vernakalant and Amiodarone for Drug-Enhanced Electrical Cardioversion of Cardioversion-Resistant Atrial Fibrillation
Phase of Trial: Phase II
Latest Information Update: 21 Mar 2013
At a glance
- Drugs Vernakalant (Primary) ; Amiodarone
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 21 Mar 2013 New trial record
- 09 Mar 2013 Primary endpoint 'Conversion-to-sinus-rhythm' has been met.
- 09 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.